Laboratoires Anios acquired by Ecolab
Context
Ecolab has completed the acquisition of 100% of Laboratoires Anios from Ardian and the Letartre family. This transaction represents a definitive exit for the private equity firm Ardian, which had supported the founding family in a 2013 LBO following a previous ownership cycle by Air Liquide. The strategic rationale for Ecolab is to establish a dominant foothold in the European hospital disinfection market, a segment where it was previously underrepresented. For Anios, the merger provides a global springboard, particularly to accelerate its expansion into the Chinese market. Over the three years of Ardian’s ownership, Anios achieved a 25% increase in revenue and a 55% jump in EBITDA, driven by a series of five strategic "bolt-on" acquisitions.
In the past, Laboratoires Anios was acquired by Ardian in 2013 as part of its expansion strategy.
Laboratoires Anios, which reported an EBITDA margin of [members only] in 2016, is valued in this transaction at an EV/EBITDA multiple of 10x–18x.
-> Deep-dive in Healthcare & Pharma market trends
Target
Founded by the Letartre family and based in Lille, Laboratoires Anios is a European leader in the hygiene and disinfection sector for hospitals, clinics, and industrial environments. The company provides holistic solutions for medical device disinfection, including endoscope washer-disinfectors, as well as products for the food and professional cleaning industries. Its business model integrates high-intensity R&D with specialized chemical manufacturing across international sites.
Ent. Value
€500M–1.5bn
Equity Value
[members only]
Multiples
EV / Revenue
2x–6x
EV / EBITDA
10x–18x
EV / EBIT
[members only]
Historical Financials (EUR)
Other operations with Laboratoires Anios
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2013 | ARDIAN | LABORATOIRES ANIOS | FRANCE | Medical Consumables |
Other operations with Ecolab
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 03/2026 | ECOLAB | COOLIT SYSTEMS | CANADA | Servers & Networks |
Similar deals in Life Sciences
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 04/2017 | BAIN CAPITAL / CINVEN | STADA | GERMANY | Generics / Labs |
| 03/2017 | ARDIAN | UNITHER | FRANCE | CDMO |
| 09/2016 | ARCHIMED | POLYPLUS | FRANCE | R&D Biotech |
| 09/2016 | ARDIAN / IXO PRIVATE EQUITY | LAGARRIGUE | FRANCE | Implants & Prosthetics |
| 06/2016 | PAI PARTNERS | ETHYPHARM | FRANCE | Pharma & Biotech |
| 06/2016 | BRIDGEPOINT / RAISE / FLEXSTONE PARTNERS | ACTEON | FRANCE | Medical Devices |
| 06/2016 | PAI PARTNERS | ATOS MEDICAL | SWEDEN | Medical Consumables |
| 05/2016 | IK PARTNERS | MARLE GROUP | FRANCE | Implants & Prosthetics |
| 03/2016 | PSP INVESTMENTS | ANTELLIQ | FRANCE | Animal Health |
| 03/2016 | CVC | DOC GENERICI | ITALY | Generics / Labs |
REFERENCES
Valuation range: EV €500M–1.5bn
Revenue range: €150–250M
EBITDA range: €50–100M
EV/Revenue range: 2x - 6x
EV/EBITDA range: 10x - 18x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Laboratoires Anios by Ecolab are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: laboratoires anios
FAQ
What transaction does this page cover?
How was the acquisition of Laboratoires Anios by Ecolab valued, and what multiples were paid?
What were Laboratoires Anios’s revenue and EBITDA at the time of the deal?
What sources support the information on this transaction?
What is mynth?